BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 27296703)

  • 1. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
    Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Renal Function Trajectory on Renal Replacement Therapy and Mortality Risk after Renal Artery Revascularization.
    Takahashi EA; Harmsen WS; Misra S
    J Vasc Interv Radiol; 2020 Apr; 31(4):592-597. PubMed ID: 31530493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
    de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
    Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Salvage with Renal Artery Stenting Improves Long-term Survival.
    Modrall JG; Trimmer C; Tsai S; Kirkwood ML; Ali M; Rectenwald JE; Timaran CH; Rosero EB
    Ann Vasc Surg; 2017 Nov; 45():106-111. PubMed ID: 28602899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
    Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
    BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
    Voskamp PWM; Dekker FW; van Diepen M; Hoogeveen EK;
    J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
    Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
    Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function changes after fenestrated endovascular aneurysm repair.
    Tran K; Fajardo A; Ullery BW; Goltz C; Lee JT
    J Vasc Surg; 2016 Aug; 64(2):273-280. PubMed ID: 27237402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease.
    Chen PM; Lai TS; Chen PY; Lai CF; Wu V; Chiang WC; Chen YM; Wu KD; Tsai TJ
    J Formos Med Assoc; 2014 Apr; 113(4):219-26. PubMed ID: 24512756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of In-Stent Restenosis in Patients with Renal Artery Stenosis.
    Takahashi EA; McKusick MA; Bjarnason H; Piryani A; Harmsen WS; Misra S
    J Vasc Interv Radiol; 2016 Nov; 27(11):1657-1662. PubMed ID: 27503035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
    Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.
    Kuo KL; Hung SC; Liu JS; Chang YK; Hsu CC; Tarng DC
    Sci Rep; 2015 Nov; 5():17150. PubMed ID: 26612282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of chronic kidney disease and renal replacement therapy in ventricular tachyarrhythmias and aborted cardiac arrest.
    Weidner K; Behnes M; Schupp T; Rusnak J; Reiser L; Taton G; Reichelt T; Ellguth D; Engelke N; Bollow A; El-Battrawy I; Ansari U; Hoppner J; Nienaber CA; Mashayekhi K; Weiß C; Akin M; Borggrefe M; Akin I
    Clin Res Cardiol; 2019 Jun; 108(6):669-682. PubMed ID: 30578436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of secondary interventions for restenosis after renal artery stenting.
    Simone TA; Brooke BS; Goodney PP; Walsh DB; Stone DH; Powell RJ; Cronenwett JL; Nolan BW
    J Vasc Surg; 2013 Sep; 58(3):687-94. PubMed ID: 23688626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of estimated glomerular filtration rates for assessment of renal function after renal artery stenting in patients with atherosclerotic renal artery stenosis.
    Crimmins GM; Madder RD; Marinescu V; Safian RD
    JACC Cardiovasc Interv; 2014 May; 7(5):543-9. PubMed ID: 24746646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.